BBH Stock Recent News Biotech ETF Market Vectors (BBH) 114.43

New Post Public Reply Private Reply Replies (0) Message Board

Nov 9, 2014 at 12:40 AM

Biotech ETF Market Vectors (BBH) 114.43 $BBH

The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF
PR Newswire - Fri Oct 31, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Amgen (Nasdaq:AMGN-Free Report), Celgene (Nasdaq:CELG-Free Report), Biogen Idec (Nasdaq:BIIB-Free Report), Market Vectors Biotech ETF (AMEX:BBH-Free Report) and SPDR S&P Biotech ETF (AMEX:XBI-Free Report).
BIIB: 320.75 (-2.72), BBH: 114.43 (-0.81), AMGN: 160.25 (-0.10), CELGZ: 3.24 (-0.04)

Buy These Top Ranked ETFs on Solid Biotech Stock Earnings - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Oct 30, 8:00AM CDT
After some solid biotech stock earnings, these top ranked health care ETFs could be intriguing buys.
BIIB: 320.75 (-2.72), XBI: 167.72 (-1.28), BBH: 114.43 (-0.81), AMGN: 160.25 (-0.10)

The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology ETF, SPDR S&P Biotech ETF, First Trust NYSE Arca Biotechnology Index Fund, Market Vectors Biotech ETF and PowerShares Dynamic Biotechnology & Genome Portfolio- GENOME
PR Newswire - Fri Oct 03, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the iShares Nasdaq Biotechnology ETF (Nasdaq:IBB-Free Report), SPDR S&P Biotech ETF (AMEX:XBI-Free Report), First Trust NYSE Arca Biotechnology Index Fund (AMEX:FBT-Free Report), Market Vectors Biotech ETF (AMEX:BBH-Free Report) and PowerShares Dynamic Biotechnology & Genome Portfolio - GENOME (AMEX

BE-Free Report).
FBT: 97.23 (-1.31), XBI: 167.72 (-1.28), BBH: 114.43 (-0.81)

The Complete Guide to Biotech ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Oct 02, 11:09AM CDT
Biotech sector appears to be back on track with fundamentals remaining attractive.
PBE: 48.56 (-0.41), FBT: 97.23 (-1.31), XBI: 167.72 (-1.28), BBH: 114.43 (-0.81), IBB: 290.14 (-3.18)

Biotech ETFs Slip on Gilead Weakness; Buying Opportunity Now? - ETF News And Commentary
Zacks Equity Research - ZACKS - Wed Sep 10, 11:00AM CDT
A look at biotech ETFs following some weakness in one of the key companies in the space, Gilead (GILD).
PBE: 48.56 (-0.41), GILD: 106.45 (-0.49), BBH: 114.43 (-0.81), IBB: 290.14 (-3.18)

Are Biotech ETFs Back on Track? - ETF News And Commentary
Zacks Equity Research - ZACKS - Wed Aug 27, 7:00AM CDT
Recent trends have been very favorable for the biotech sector, but can this run continue?
BIIB: 320.75 (-2.72), PBE: 48.56 (-0.41), GILD: 106.45 (-0.49), FBT: 97.23 (-1.31), XBI: 167.72 (-1.28), IBB: 290.14 (-3.18), BBH: 114.43 (-0.81)

After Recent Surge, Are Biotech ETFs Back on Track? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Aug 27, 7:00AM CDT
Recent trends have been very favorable for the biotech sector, but can this run continue?
BIIB: 320.75 (-2.72), PBE: 48.56 (-0.41), GILD: 106.45 (-0.49), FBT: 97.23 (-1.31), XBI: 167.72 (-1.28), IBB: 290.14 (-3.18), BBH: 114.43 (-0.81)

Last Week's ETF Highlights: MLP and Biotech Funds Soar, Volatility Sinks - ETF News And Commentary
Zacks Equity Research - ZACKS - Wed Aug 20, 7:00AM CDT
Which ETFs led the market higher and lower last week?
ZROZ: 109.39 (+1.34), KMI: 38.75 (+0.22), VXX: 29.03 (-0.42), FCG: 15.60 (+0.86), BBH: 114.43 (-0.81), MLPI: 43.92 (+0.93), CVOL: 1.13 (+0.02)

Biotech Earnings Put These ETFs in Focus - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Jul 31, 9:01AM CDT
Following solid results from Amgen, among others, these biotech ETFs could be ones to watch.
GILD: 106.45 (-0.49), PJP: 66.42 (-1.50), AMGN: 160.25 (-0.10), IBB: 290.14 (-3.18), BBH: 114.43 (-0.81), CELG: 106.45 (-0.69)

The Fed's Valuation Concerns Put These Growth ETFs in Focus - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Jul 17, 9:00AM CDT
Thanks to Yellen and her comments, these high growth ETFs could be in focus.
SOCL: 19.14 (+0.01), VB: 116.08 (+0.24), IBB: 290.14 (-3.18), BBH: 114.43 (-0.81), IWM: 116.71 (+0.18)

The Zacks Analyst Blog Highlights:Vertex Pharmaceuticals, Market Vectors Biotech ETF, iShares Nasdaq Biotechnology ETF, First Trust NYSE Arca Biotechnology Index Fund, PowerShares Dynamic Biotechnology & Genome Portfolio and SPDR S&P Biotech ETF
PR Newswire - Thu Jun 26, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Vertex Pharmaceuticals (Nasdaq:VRTX-Free Report), Market Vectors Biotech ETF (AMEX:BBH-Free Report), iShares Nasdaq Biotechnology ETF (Nasdaq:IBB-Free Report), First Trust NYSE Arca Biotechnology Index Fund (AMEX:FBT-Free Report), PowerShares Dynamic Biotechnology & Genome Portfolio (AMEX

BE-Free Report) and SPDR S&P Biotech ETF (AMEX:XBI-Free Report).
PBE: 48.56 (-0.41), FBT: 97.23 (-1.31), BBH: 114.43 (-0.81)

Vertex Pharma Pushes Biotech ETFs Higher - ETF News And Commentary
Sweta Killa - ZACKS - Wed Jun 25, 1:00PM CDT
The positive trial results of a cystic fibrosis send Vertex Pharmaceuticals and these biotech ETFs higher on Tuesday trading session.
PBE: 48.56 (-0.41), FBT: 97.23 (-1.31), XBI: 167.72 (-1.28), IBB: 290.14 (-3.18), BBH: 114.43 (-0.81)

Biotech HOLDRs Trust Shares Down 10.5% Since SmarTrend's Sell Call (BBH)
Comtex SmarTrend(R) - Mon Mar 31, 9:27AM CDT
SmarTrend identified a Downtrend for Biotech HOLDRs Trust (AMEX:BBH) on March 7th, 2014 at $100.08. In approximately 3 weeks, Biotech HOLDRs Trust has returned 10.52% as of today's recent price of $89.55.
BBH: 114.43 (-0.81)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rachel Noble Joins AGS: Signals Strategy Shift

A Tactical Addition to American Global Strategies The chessboard of global security just saw a savvy new player join American Global Strategies (AGS). Rachel Noble, a name that echoes through the halls of Australia's national security apparatus, has joined AGS as Senior Advisor. This isn't your garden-variety hire—this is a strategic power move. From Down Under to the...

From Vätternrundan to Göta Canal: Circularity in Action

Sustainability in Action: Vätternrundan Leads the Way Ever thought your banana peel could contribute to cultural heritage? That’s the twist here. Vätternrundan 2026 hit the mark by turning food waste into a natural asset along the Göta Canal. It's a glimpse of the future where waste isn't a by-product but a resource. Transforming Waste into Growth In a world where...

Yellow Phosphorus Market Set for Growth to $6.21B

What's Cooking in the Phosphorus Market? Kicking off with some seasoning for your thoughts. Picture this: yellow phosphorus isn't just another chemical compound sitting quietly in a lab fridge. Nope, we've got an industrial powerhouse here, folks. Projected to leap from USD 4.84 billion in 2026 to a hearty USD 6.21 billion by 2031, this market's chugging along at a decent...

Retail's AI Ambitions Clash with In-Store Data Realities

AI's Lofty Goals Meet Retail's Messy Reality I swear, all this chatter about AI transforming retail sounds grand until you dig into the messy trenches, right? This latest Scandit survey lays it bare: retailers have got their AI visions sprinting ahead of the stock data realities inside their stores. Seems those shiny new systems rely on stock data that matches what's...

Entenmann's Packs Seasonal Joy into Limited-Time Treats

Winter Treats Stepping into the Limelight Another year, another holiday season descended upon us—the calorie indulgence is real, folks. There’s something criminally comforting about these recurring flavors, especially when Entenmann’s and Little Bites decide it’s time to drop some trademark nostalgia into the frosty mix. Pop these limited-edition sweets on your...

EZ MOUSE Revolutionizes Multi-Device Computing Control

A New Dawn for Multi-Device Users Sometimes, the best ideas are born from sheer frustration. Take this EZ MOUSE invention, for example. Some creative soul from Sun Prairie, Wisc. had enough of juggling multiple computer mice for their array of desktops and laptops. In response, they hatched the idea for a patent-pending gadget that aims to streamline operations across...

Rising Tide: Luxury Cruises Attract Broader Audience

The Lure of the High Seas Who knew luxury cruises would ever shed their elitist skin and become every man's (and woman's) dream? That's what the latest survey from Cruiseline.com and Shipmate is scribbling across the page. Once a playground for the glitzy crowd, luxury cruising now appeals to a broader swath of travelers. They’ve tossed tradition overboard and are...

Bell Mare to Elevate Senior Living in DC Suburbs

Bringing Upscale Senior Living to Potomac Nothing like luxury to sweeten the twilight years, huh? The Bell Mare at River Road is gearing up to redefine senior living in Potomac, Maryland, aiming to open its doors in Fall 2028. We're talking 94 swanky units—68 for assisted living and 26 for memory care. And these aren't your grandma's digs. Studio, one-, and two-bedroom...

Burtch Works Joins Databricks: Fueling AI Success

Game-Changer for AI Talent Market First off, let me tell you, in this data-driven world, finding solid AI talent is like hitting the jackpot. Burtch Works teaming up with Databricks? That's like leaping into a goldmine fully prepared. We're talking about forward-deployed engineers and specialized AI talent coming straight to your door. Closing the Impossible Talent Gap...

Charitable Giving Turbocharges E-commerce Conversion Rates

Charitable Giving: The Secret Sauce for E-commerce Success In an e-commerce arena teeming with bland sameness, charitable giving is proving to be a game-changing hook. That's right—brands partnering with Change and DailyKarma have found a magic formula where customers flourish and causes benefit. With over $7.4 million in donations spread across more than 3 million...